Physician

Ramaswamy Vellore Sriraman, M.D.

According to 2025 Medicare claims, Ramaswamy Sriraman, M.D. (NPI: 1134230857) practices psychiatry in the Goldsboro, NC market, with the plurality of this provider's patient population coming from Wayne, NC. This provider's primary affiliated billing organization is WAYNESBORO FAMILY CLINIC (NPI: 1760417570; TIN: 581477622) and primary practice location at 27534-2240.

Sriraman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 176 traditional Medicare patients, billed 2,032 HCPCS/CPT codes, and received $105,011 in Medicare payments. The top billing code was 90791 (Psychiatric diagnostic evaluation). Part D data shows 3,926 prescription claims across 225 beneficiaries totaling $1,161,393 in drug costs, led by Ingrezza (Valbenazine Tosylate). Open Payments data shows 114 records totaling $2,407. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $154,226 to $105,011. In contrast, Part D prescription costs have risen steadily, from $494,422 to $1,161,393. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$204K$409K2015 Medicare payment: $154,226 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $281,318 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $408,752 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $254,498 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $194,210 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $206,868 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $195,489 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $161,871 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $124,635 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $105,011 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154253,394$154,226
20161,1975,853$281,318
20171,36010,491$408,752
20186045,507$254,498
20194134,285$194,210
20203044,388$206,868
20212823,673$195,489
20222313,031$161,871
20232142,406$124,635
20241762,032$105,011

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$581K$1.2M2015 Drug cost: $494,422 (USD; Tot_Drug_Cst)2016 Drug cost: $408,440 (USD; Tot_Drug_Cst)2017 Drug cost: $600,771 (USD; Tot_Drug_Cst)2018 Drug cost: $642,499 (USD; Tot_Drug_Cst)2019 Drug cost: $705,224 (USD; Tot_Drug_Cst)2020 Drug cost: $396,108 (USD; Tot_Drug_Cst)2021 Drug cost: $569,251 (USD; Tot_Drug_Cst)2022 Drug cost: $745,969 (USD; Tot_Drug_Cst)2023 Drug cost: $969,260 (USD; Tot_Drug_Cst)2024 Drug cost: $1,161,393 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152884,548$494,422
20162884,948$408,440
20174587,329$600,771
20184568,029$642,499
20194216,895$705,224
20203005,365$396,108
20212554,987$569,251
20222624,647$745,969
20232434,103$969,260
20242253,926$1,161,393

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90791Psychiatric diagnostic evaluation6465$100
90837Psychotherapy, 1 hour69359$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more93353$50
84439Thyroxine (thyroid chemical), free61127$9
36415Insertion of needle into vein for collection of blood sample65141$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IngrezzaValbenazine Tosylate982,940$819,163
VraylarCariprazine Hcl621,860$94,548
RexultiBrexpiprazole29870$40,868
Invega SustennaPaliperidone Palmitate15420$28,049
LybalviOlanzapine/Samidorphan Malate11314$16,932

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.114$2,407ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ramaswamy Vellore Sriraman, M.D.?

Tedicare shows public-source Medicare data for Ramaswamy Vellore Sriraman, M.D. (NPI 1134230857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramaswamy Vellore Sriraman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ramaswamy Vellore Sriraman, M.D.?

Ramaswamy Vellore Sriraman, M.D. is linked to WAYNESBORO FAMILY CLINIC (billing NPI 1760417570) in the available physician profile data.

Does Ramaswamy Vellore Sriraman, M.D. have Open Payments data?

Ramaswamy Vellore Sriraman, M.D. has 114 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.